Cargando…
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis characterised by clonal expansion of histiocytes in various organs. These induce an inflammatory environment, which leads to damage of the affected areas. Recently, a new disease entity was proposed encompassing key features of ECD...
Autores principales: | Portegys, Jan, Heidemeier, Anke, Rosenwald, Andreas, Gernert, Michael, Fröhlich, Matthias, Hueper, Sebastian, Strunz, Patrick Pascal, Rasche, Leo, Schmalzing, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884847/ https://www.ncbi.nlm.nih.gov/pubmed/36693681 http://dx.doi.org/10.1136/rmdopen-2022-002852 |
Ejemplares similares
-
Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses
por: Mavrogenis, Andreas F., et al.
Publicado: (2018) -
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis
por: Salama, Hind Abdin, et al.
Publicado: (2021) -
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra
por: Podestà, Manuel Alfredo, et al.
Publicado: (2014) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
High-Dose Methotrexate for the Treatment of Relapsed Central Nervous System Erdheim-Chester Disease
por: Ho, Prahlad, et al.
Publicado: (2014)